{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T01:20:55Z","timestamp":1769131255047,"version":"3.49.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["003379122"],"award-info":[{"award-number":["003379122"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL138154"],"award-info":[{"award-number":["K23HL138154"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["003379122"],"award-info":[{"award-number":["003379122"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL138154"],"award-info":[{"award-number":["K23HL138154"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Lung transplantation can extend the lives of individuals with advanced cystic fibrosis (CF). Until March 2023, the Lung Allocation Score (LAS) was used in the United States to determine transplant priority. Certain clinical events or attributes (\u201crisk events\u201d) that are not included in the LAS (e.g., massive hemoptysis) are relatively common and prognostically important in CF and may prompt an exception request to increase priority for donor lungs. The new Lung Composite Allocation Score (CAS) also allows for exceptions based on the same principles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the frequency of LAS exceptions in persons with CF (PwCFs) listed for lung transplantation and assess whether LAS exceptions are associated with improved waitlist outcomes for PwCFs compared with similarly \u201cat-risk\u201d individuals without LAS exceptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A merged dataset combining data from the CF Foundation Patient Registry and the Organ Procurement and Transplantation Network (2005\u20132019) was used to identify PwCFs listed for lung transplantation. We compared waitlist outcomes between PwCFs with a LAS exception versus those without an exception despite having a risk event. Risk events were defined as an episode of massive hemoptysis, pneumothorax, at least three moderate\/severe pulmonary exacerbations, and\/or a decrease in forced expiratory volume in 1\u2009second by \u2a7e30% predicted (absolute) in the prior 12 months. Analyses were performed using competing risk regression with time to transplantation as the primary outcome and death without a transplant as a competing risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 3,538 listings from 3,309 candidates, 2% of listings (n\u2009=\u200981) had at least one exception. Candidates with an exception and those with a risk event but no exception received lung transplants more slowly than people without an exception or risk event (subdistribution hazard ratio [95% confidence interval]: LAS exception cohort, 0.66 [0.52\u20130.85]; risk event cohort without exceptions, 0.79 [0.72\u20130.86]). There was no difference between those with LAS exceptions and those at risk without LAS exceptions: subdistribution hazard ratio, 0.84 (0.66\u20131.08).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LAS exceptions are rare in PwCFs listed for lung transplantation. LAS exceptions resulted in a similar time to transplantation for PwCFs compared with similarly at-risk individuals. As we enter the CAS era, these LAS-based results are pertinent to improve risk stratification among PwCFs being considered for lung transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202306-509oc","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T15:31:34Z","timestamp":1698247894000},"page":"271-278","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":0,"title":["Lung Allocation Score Exceptions in Persons with Cystic Fibrosis Undergoing Lung Transplant"],"prefix":"10.1093","volume":"21","author":[{"given":"Omar F.","family":"Bayomy","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda C.","family":"Bradford","sequence":"additional","affiliation":[{"name":"Core for Biostatistics, Epidemiology and Analytics in Research, Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tijana","family":"Milinic","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha G.","family":"Kapnadak","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Morrell","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-6733","authenticated-orcid":false,"given":"Erika D.","family":"Lease","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"Goss","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, and"},{"name":"Division of Pulmonary Medicine, Department of Pediatrics, University of Washington, Seattle, Washington; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen J.","family":"Ramos","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"2026012203135811300_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak","year":"2020","journal-title":"J Cyst Fibros"},{"key":"2026012203135811300_bib2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.202110-2249OC","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on CFTR function in patients with cystic fibrosis and one or two F508del alleles","volume":"205","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203135811300_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203135811300_bib4","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1513\/AnnalsATS.202102-220RL","article-title":"Efficacy of elexacaftor\/tezacaftor\/ivacaftor in advanced cystic fibrosis lung disease","volume":"18","author":"Djavid","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203135811300_bib5","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"2026012203135811300_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012203135811300_bib7","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.chest.2017.01.019","article-title":"Heterogeneity in survival in adult patients with cystic fibrosis with FEV1 &lt; 30% of predicted in the United States","volume":"151","author":"Ramos","year":"2017","journal-title":"Chest"},{"key":"2026012203135811300_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.healun.2020.02.010","article-title":"Lung transplantation for cystic fibrosis","volume":"39","author":"Yeung","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2026012203135811300_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.chest.2021.04.010","article-title":"Survival and lung transplant outcomes for individuals with advanced cystic fibrosis lung disease living in the United States and Canada: an analysis of national registries","volume":"160","author":"Ramos","year":"2021","journal-title":"Chest"},{"key":"2026012203135811300_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J Cyst Fibros"},{"key":"2026012203135811300_bib11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1164\/rccm.201907-1385ED","article-title":"Call for changes in lung allocation to reduce transplant wait-list mortality for cystic fibrosis","volume":"200","author":"Nolley","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203135811300_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1164\/rccm.201902-0252OC","article-title":"Effect of Including important clinical variables on accuracy of the lung allocation score for cystic fibrosis and chronic obstructive pulmonary disease","volume":"200","author":"Lehr","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203135811300_bib13","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jclinepi.2014.12.010","article-title":"A statistical model to predict one-year risk of death in patients with cystic fibrosis","volume":"68","author":"Aaron","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"2026012203135811300_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"key":"2026012203135811300_bib15","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1111\/ajt.17160","article-title":"Expected effect of the lung Composite Allocation Score system on US lung transplantation","volume":"22","author":"Valapour","year":"2022","journal-title":"Am J Transplant"},{"key":"2026012203135811300_bib16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.healun.2017.03.001","article-title":"Characteristics of lung allocation score exception requests submitted to the national Lung Review Board","volume":"36","author":"Wille","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2026012203135811300_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.healun.2020.12.001","article-title":"Bridging the survival gap in cystic fibrosis: an investigation of lung transplant outcomes in Canada and the United States","volume":"40","author":"Stephenson","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2026012203135811300_bib18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","article-title":"The Cystic Fibrosis Foundation Patient Registry. Design and methods of a national observational disease registry","volume":"13","author":"Knapp","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203135811300_bib19","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1513\/AnnalsATS.202202-110OC","article-title":"Hemoptysis and the risk for lung transplant or death without transplant in individuals with cystic fibrosis in the United States","volume":"19","author":"Bayomy","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203135811300_bib20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1164\/rccm.201002-0157OC","article-title":"Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax","volume":"182","author":"Flume","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203135811300_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1378\/chest.128.2.729","article-title":"Massive hemoptysis in cystic fibrosis","volume":"128","author":"Flume","year":"2005","journal-title":"Chest"},{"key":"2026012203135811300_bib22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the Global Lung Function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"2026012203135811300_bib23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1183\/09031936.00187314","article-title":"Global Lung Function Initiative equations improve interpretation of FEV1 decline among patients with cystic fibrosis","volume":"46","author":"Stanojevic","year":"2015","journal-title":"Eur Respir J"},{"key":"2026012203135811300_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1164\/rccm.201507-1279OC","article-title":"Short stature and access to lung transplantation in the United States. A cohort study","volume":"193","author":"Sell","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203135811300_bib25","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1513\/AnnalsATS.202001-030OC","article-title":"Impact of socioeconomic position on access to the U.S. lung transplant waiting list in a matched cystic fibrosis cohort","volume":"17","author":"Lehr","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203135811300_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1513\/AnnalsATS.201808-564PS","article-title":"Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals","volume":"16","author":"Lederer","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203135811300_bib27","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2026012203135811300_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thorsurg.2014.09.001","article-title":"Candidacy for lung transplant and lung allocation","volume":"25","author":"Lehr","year":"2015","journal-title":"Thorac Surg Clin"},{"key":"2026012203135811300_bib29","author":"Organ Procurement & Transplantation Network","year":"2023"},{"key":"2026012203135811300_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajt.2022.11.012","article-title":"Miscalibration of lung allocation models leads to inaccurate waitlist mortality predictions","volume":"23","author":"Dalton","year":"2023","journal-title":"Am J Transplant"},{"key":"2026012203135811300_bib31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.chest.2022.08.2217","article-title":"Refining the lung allocation score models fails to improve discrimination performance","volume":"163","author":"Dalton","year":"2023","journal-title":"Chest"},{"key":"2026012203135811300_bib32","author":"Organ Procurement & Transplantation Network","year":"2022"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/2\/271\/66018172\/annalsats_21_2_271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/2\/271\/66018172\/annalsats_21_2_271.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:14:50Z","timestamp":1769069690000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/21\/2\/271\/8382063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202306-509oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"2023-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}